(Q36478109)

14 August 2017

1 reference

title

Emerging biological treatments in inflammatory bowel diseases. (English)

1 reference

inflammatory bowel diseases

14 August 2017

main subject

0 references

1

Gert Van Assche

0 references

Paul Rutgeerts

series ordinal

3

object named as

Paul Rutgeerts

0 references

Séverine Vermeire

series ordinal

2

object named as

Séverine Vermeire

0 references

publication date

1 January 2006

1 reference

14 August 2017

1 reference

14 August 2017

volume

24

1 reference

14 August 2017

issue

1-2

1 reference

14 August 2017

page(s)

131-136

1 reference

Intravenous hydrocortisone premedication reduces antibodies to infliximab in Crohn's disease: a randomized controlled trial

14 August 2017

cites work

1 reference

Infliximab in moderately severe glucocorticoid resistant ulcerative colitis: a randomised controlled trial.

21 January 2018

1 reference

Infliximab as rescue therapy in severe to moderately severe ulcerative colitis: a randomized, placebo-controlled study.

21 January 2018

1 reference

Should adults be screened for celiac disease? What are the benefits and harms of screening?

21 January 2018

1 reference

Ornidazole for prophylaxis of postoperative Crohn's disease recurrence: a randomized, double-blind, placebo-controlled trial

21 January 2018

1 reference

A controlled trial of natalizumab for relapsing multiple sclerosis

21 January 2018

1 reference

Natalizumab for active Crohn's disease

21 January 2018

1 reference

Progressive multifocal leukoencephalopathy after natalizumab therapy for Crohn's disease

21 January 2018

1 reference

Progressive multifocal leukoencephalopathy complicating treatment with natalizumab and interferon beta-1a for multiple sclerosis

21 January 2018

1 reference

Progressive multifocal leukoencephalopathy in a patient treated with natalizumab

21 January 2018

1 reference

Treatment of ulcerative colitis with a humanized antibody to the alpha4beta7 integrin

21 January 2018

1 reference

A randomised, controlled, double blind, escalating dose study of alicaforsen enema in active ulcerative colitis

21 January 2018

1 reference

An enema formulation of alicaforsen, an antisense inhibitor of intercellular adhesion molecule-1, in the treatment of chronic, unremitting pouchitis

21 January 2018

1 reference

Anti-interleukin-12 antibody for active Crohn's disease

21 January 2018

1 reference

Basiliximab (anti-CD25) in combination with steroids may be an effective new treatment for steroid-resistant ulcerative colitis.

21 January 2018

1 reference

A pilot randomized trial of a human anti-interleukin-6 receptor monoclonal antibody in active Crohn's disease

21 January 2018

1 reference

Long-term outcome of treatment with intravenous cyclosporin in patients with severe ulcerative colitis

21 January 2018

1 reference

Influence of Immunogenicity on the Long-Term Efficacy of Infliximab in Crohn's Disease

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1159/000090316

1 reference

14 August 2017

1 reference